Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom. Unit of Experimental Therapeutics, Institute of Cancer Science, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Clin Cancer Res. 2015 Feb 15;21(4):882-8. doi: 10.1158/1078-0432.CCR-14-1686. Epub 2014 Dec 3.
The tumor microenvironment is recognized as an important determinant of progression and outcome in colorectal cancer. The aim of the present study was to evaluate a novel tumor microenvironment-based prognostic score, based on histopathologic assessment of the tumor inflammatory cell infiltrate and tumor stroma, in patients with primary operable colorectal cancer.
Using routine pathologic sections, the tumor inflammatory cell infiltrate and stroma were assessed using Klintrup-Mäkinen (KM) grade and tumor stroma percentage (TSP), respectively, in 307 patients who had undergone elective resection for stage I-III colorectal cancer. The clinical utility of a cumulative score based on these characteristics was examined.
On univariate analysis, both weak KM grade and high TSP were associated with reduced survival (HR, 2.42; P = 0.001 and HR, 2.05; P = 0.001, respectively). A cumulative score based on these characteristics, the Glasgow Microenvironment Score (GMS), was associated with survival (HR, 1.93; 95% confidence interval, 1.36-2.73; P < 0.001), independent of TNM stage and venous invasion (both P < 0.05). GMS stratified patients in to three prognostic groups: strong KM (GMS = 0), weak KM/low TSP (GMS = 1), and weak KM/high TSP (GMS = 2), with 5-year survival of 89%, 75%, and 51%, respectively (P < 0.001). Furthermore, GMS in combination with node involvement, venous invasion, and mismatch repair status further stratified 5-year survival (92% to 37%, 93% to 27%, and 100% to 37%, respectively).
The present study further confirms the clinical utility of assessment of the tumor microenvironment in colorectal cancer and introduces a simple, routinely available prognostic score for the risk stratification of patients with primary operable colorectal cancer.
肿瘤微环境被认为是结直肠癌进展和预后的重要决定因素。本研究旨在评估一种基于原发性可切除结直肠癌患者肿瘤炎症细胞浸润和肿瘤基质的组织病理学评估的新型肿瘤微环境预后评分。
使用常规病理切片,分别使用 Klintrup-Mäkinen(KM)分级和肿瘤基质百分比(TSP)评估肿瘤炎症细胞浸润和肿瘤基质,共 307 例接受 I-III 期结直肠癌选择性切除术的患者。检查了基于这些特征的累积评分的临床应用。
在单因素分析中,KM 分级较弱和 TSP 较高均与生存时间缩短相关(HR,2.42;P=0.001 和 HR,2.05;P=0.001)。基于这些特征的累积评分,格拉斯哥微环境评分(GMS)与生存相关(HR,1.93;95%置信区间,1.36-2.73;P<0.001),与 TNM 分期和静脉侵犯独立(均 P<0.05)。GMS 将患者分为三个预后组:KM 强(GMS=0)、KM 弱/TSP 低(GMS=1)和 KM 弱/TSP 高(GMS=2),5 年生存率分别为 89%、75%和 51%(P<0.001)。此外,GMS 联合淋巴结受累、静脉侵犯和错配修复状态进一步分层了 5 年生存率(分别为 92%至 37%、93%至 27%和 100%至 37%)。
本研究进一步证实了评估结直肠癌肿瘤微环境的临床应用,并引入了一种简单、常规可用的预后评分,用于原发性可切除结直肠癌患者的风险分层。